Clinical Trial Update: Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant immunotherapy combined with chemotherapy for stage I-IIIB non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Peking Union Medical College | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN